What happens when a patient who is prescribed buprenorphine undergoes surgery? Experts say they should continue the medication, predominantly prescribed for opioid use disorder, throughout the entire perioperative period. It doesn’t need to be stopped, Lynn Kohan, MD, the medical director of the Pain Management Center told Pain Medicine News.
Other News
Other news from bridge therapeutics
New York, New York – August 29, 2022: Bridge Therapeutics, a developmental stage pharmaceutical company, today reported continued progress towards Phase 3 FDA approval of BT 219, a patented combination of Buprenorphine and Naloxone for Opioid Use Disorder (OUD). Simultaneously, Bridge reported that Darren Prince, an internationally recognized speaker and advisor on matters of addiction and mental health recovery…
Treatment advocates are hailing those new laws as well as several recent changes to federal regulation designed to reduce the stigma around addiction, close gaps in treatment and expand access to critical medications, including naloxone and buprenorphine, a highly effective intervention for opioid addiction.
In a series of presentations at the 2021 virtual meeting of the North American Neuromodulation Society, Lynn R. Webster, MD, and his colleagues concluded that the novel agent was not associated with significantly decreased respiratory drive and also may have a lower risk for abuse potential than oxycodone.
In a Jan. 26 statement, the American Society of Addiction Medicine, the National Council for Behavioral Health and a handful of other addiction advocacy groups urged Congress to eliminate the training requirement as quickly as possible. “As clinicians and advocates on the frontlines of the addiction and overdose crisis, we call on congressional leaders to…
The Department of Health & Human Services has issued guidance to do away with the so-called X-waiver, a move the agency said will increase the number of providers able to deliver medication-assisted treatment and therefore increase patient access to care. “The medical evidence is clear: access to medication-assisted treatment, including buprenorphine that can be prescribed…
“Companies with limited R&D resources can forgo costly and more risky discovery and development of new chemical entities and instead make incremental innovations to existing drugs. In this manner, companies can use the 505(b)(2) regulatory pathway to repurpose or reposition drugs for new indication,” notes Dr. Babul. A 505(b)(2) NDA may differ from a previously…
Dr. David Fiellin, Director of Yale Program in Addiction Medicine, said, “For individuals who come to an emergency department after an opioid overdose and receive buprenorphine, their one-year mortality rate falls by 40%”. The increased recognition of the benefits of buprenorphine comes at a critical time, the researchers said.
The pandemic has led to regulatory changes: Treatment can now be entirely virtual, including the first appointment. Medicare now pays providers the same for a video appointment as a conventional one — many insurers and Medicaid programs have followed. Patients can get a month’s prescription for buprenorphine instead of just a week’s. Forty percent of…
Dr. Michael Kittay is a Harvard-trained psychiatrist certified by the American Board of Addiction Medicine. In this article Dr. Kittay discusses how buprenorphine can greatly reduce deaths from opioid addiction. September 6, 2019 Dr. Kittay writes “In March 2019, a report to Florida’s attorney general recognized MAT [Medically Assisted Therapy] as a key component of…